Biosimilars Versus ‘Biobetters’—a Regulator’s Perspective

GaBI Journal - Belgium
doi 10.5639/gabij.2014.0304.039
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pro Pharma Communications International

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy